Repligen (RGEN) Tops Q3 EPS by 14c, Raises FY Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $184.32 -1.3%
Revenue Growth %: +9.4%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +9.4%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.78, $0.14 better than the analyst estimate of $0.64. Revenue for the quarter came in at $178.2 million versus the consensus estimate of $163.97 million.
GUIDANCE:
Repligen sees FY2021 EPS of $2.86-$2.91, versus the consensus of $2.68. Repligen sees FY2021 revenue of $655-665 million, versus the consensus of $640.6 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
